Insurers sue Merck for 'monopolistic scheme' to delay generics of blockbuster cholesterol drug

Insurers Centene and Humana have sued Merck & Co., alleging the drugmaker's "monopolistic scheme" delayed generic versions of its blockbuster cholesterol drug Zetia from coming to market, causing the insurers to pay higher prices for years.